177 related articles for article (PubMed ID: 36868225)
21. Endoplasmic Reticulum Stress, Calcium Dysregulation and Altered Protein Translation: Intersection of Processes That Contribute to Cancer Cachexia Induced Skeletal Muscle Wasting.
Isaac ST; Tan TC; Polly P
Curr Drug Targets; 2016; 17(10):1140-6. PubMed ID: 25882219
[TBL] [Abstract][Full Text] [Related]
22. Cancer Cachexia and MicroRNAs.
Camargo RG; Quintas Teixeira Ribeiro H; Geraldo MV; Matos-Neto E; Neves RX; Carnevali LC; Donatto FF; Alcântara PS; Ottoch JP; Seelaender M
Mediators Inflamm; 2015; 2015():367561. PubMed ID: 26504359
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of cancer cachexia‑induced muscle atrophy (Review).
Yang W; Huang J; Wu H; Wang Y; Du Z; Ling Y; Wang W; Wu Q; Gao W
Mol Med Rep; 2020 Dec; 22(6):4967-4980. PubMed ID: 33174001
[TBL] [Abstract][Full Text] [Related]
24. [Sarcopenia and Cachexia-associated Risk in Surgery].
van der Kroft G; Olde Damink SWM; Neumann UP; Lambertz A
Zentralbl Chir; 2021 Jun; 146(3):277-282. PubMed ID: 34154007
[TBL] [Abstract][Full Text] [Related]
25. Mouse models of cancer-induced cachexia: Hind limb muscle mass and evoked force as readouts.
Jourdain M; Melly S; Summermatter S; Hatakeyama S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2415-2420. PubMed ID: 29969629
[TBL] [Abstract][Full Text] [Related]
26. Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?
Mueller TC; Bachmann J; Prokopchuk O; Friess H; Martignoni ME
BMC Cancer; 2016 Feb; 16():75. PubMed ID: 26856534
[TBL] [Abstract][Full Text] [Related]
27. Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: three peas in a pod? - analysis from a multicenter cross sectional study.
Solheim TS; Blum D; Fayers PM; Hjermstad MJ; Stene GB; Strasser F; Kaasa S
Acta Oncol; 2014 Apr; 53(4):539-46. PubMed ID: 23998647
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
29. Myokines in treatment-naïve patients with cancer-associated cachexia.
de Castro GS; Correia-Lima J; Simoes E; Orsso CE; Xiao J; Gama LR; Gomes SP; Gonçalves DC; Costa RGF; Radloff K; Lenz U; Taranko AE; Bin FC; Formiga FB; de Godoy LGL; de Souza RP; Nucci LHA; Feitoza M; de Castro CC; Tokeshi F; Alcantara PSM; Otoch JP; Ramos AF; Laviano A; Coletti D; Mazurak VC; Prado CM; Seelaender M
Clin Nutr; 2021 Apr; 40(4):2443-2455. PubMed ID: 33190987
[TBL] [Abstract][Full Text] [Related]
30. Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model.
Chen SZ; Xiao JD
Tumour Biol; 2014 Jan; 35(1):323-32. PubMed ID: 23959470
[TBL] [Abstract][Full Text] [Related]
31. Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia.
Lemecha M; Chalise JP; Takamuku Y; Zhang G; Yamakawa T; Larson G; Itakura K
Mol Metab; 2022 Dec; 66():101612. PubMed ID: 36243318
[TBL] [Abstract][Full Text] [Related]
32. An immune-sympathetic neuron communication axis guides adipose tissue browning in cancer-associated cachexia.
Xie H; Heier C; Meng X; Bakiri L; Pototschnig I; Tang Z; Schauer S; Baumgartner VJ; Grabner GF; Schabbauer G; Wolinski H; Robertson GR; Hoefler G; Zeng W; Wagner EF; Schweiger M; Zechner R
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35210363
[TBL] [Abstract][Full Text] [Related]
33. Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation.
Tsoli M; Schweiger M; Vanniasinghe AS; Painter A; Zechner R; Clarke S; Robertson G
PLoS One; 2014; 9(3):e92966. PubMed ID: 24667661
[TBL] [Abstract][Full Text] [Related]
34. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
Talbert EE; Guttridge DC
Semin Cell Dev Biol; 2016 Jun; 54():82-91. PubMed ID: 26385617
[TBL] [Abstract][Full Text] [Related]
35. Adipose tissue dysfunction in cancer cachexia.
Daas SI; Rizeq BR; Nasrallah GK
J Cell Physiol; 2018 Jan; 234(1):13-22. PubMed ID: 30078199
[TBL] [Abstract][Full Text] [Related]
36. [Pathogenesis of cachexia in malignant tumors].
Arkh Patol; 2005; 67(5):51-6. PubMed ID: 16323484
[TBL] [Abstract][Full Text] [Related]
37. Catabolic mediators of cancer cachexia.
Tisdale MJ
Curr Opin Support Palliat Care; 2008 Dec; 2(4):256-61. PubMed ID: 19069310
[TBL] [Abstract][Full Text] [Related]
38. On our way to targeted therapy for cachexia in cancer?
Boddaert MS; Gerritsen WR; Pinedo HM
Curr Opin Oncol; 2006 Jul; 18(4):335-40. PubMed ID: 16721127
[TBL] [Abstract][Full Text] [Related]
39. The influence of different muscle mass measurements on the diagnosis of cancer cachexia.
Blauwhoff-Buskermolen S; Langius JAE; Becker A; Verheul HMW; de van der Schueren MAE
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):615-622. PubMed ID: 28447434
[TBL] [Abstract][Full Text] [Related]
40. Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies.
Baracos VE
Cancer; 2001 Sep; 92(6 Suppl):1669-77. PubMed ID: 11598885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
